Basic Information
| RNALocate ID: | RLID:11001997 |
| RNA Symbol: | hsa-miR-206 |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-206 |
| RNA ID: | miRBase:MIMAT0000462 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001857 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11001995 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
| RLID:11001996 | Exosome | Brain tissue | 23382797 |
| RLID-D:11000390 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001186 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-mir-206 | Inflammatory bowel disease | MNDR-E-MI-27228 |
| MNDR | hsa-mir-206 | Lymphoplasmacytic lymphoma | MNDR-E-MI-27229 |
| MNDR | hsa-mir-206 | Oral squamous cell carcinoma | MNDR-E-MI-27230 |
| MNDR | hsa-miR-206 | Oral squamous cell carcinoma | MNDR-E-MI-27231 |
| MNDR | hsa-miR-206 | Medulloblastoma | MNDR-E-MI-27232 |
| MNDR | hsa-mir-206 | Medulloblastoma | MNDR-E-MI-27233 |
| MNDR | hsa-miR-206 | Autism spectrum disorder | MNDR-E-MI-27234 |
| MNDR | hsa-miR-206 | Estrogen-receptor positive breast cancer | MNDR-E-MI-27235 |
| MNDR | hsa-miR-206 | Progesterone-receptor positive breast cancer | MNDR-E-MI-27236 |
| MNDR | hsa-miR-206 | Her2-receptor positive breast cancer | MNDR-E-MI-27237 |
| MNDR | hsa-miR-206 | Breast cancer luminal b | MNDR-E-MI-27238 |
| MNDR | hsa-miR-206 | Anencephaly | MNDR-E-MI-27239 |
| MNDR | hsa-mir-206 | Waldenstrom macroglobulinemia | MNDR-E-MI-27240 |
| MNDR | hsa-mir-206 | Miyoshi myopathy | MNDR-E-MI-27241 |
| MNDR | hsa-mir-206 | Colorectal carcinoma | MNDR-E-MI-27242 |
| MNDR | hsa-mir-206 | Melanoma and neural system tumor syndrome | MNDR-E-MI-27243 |
| MNDR | hsa-miR-206 | Dermatomyositis | MNDR-E-MI-27244 |
| MNDR | hsa-mir-206 | Dermatomyositis | MNDR-E-MI-27245 |
| MNDR | hsa-miR-206 | Prostate cancer | MNDR-E-MI-27246 |
| MNDR | hsa-mir-206 | Prostate cancer | MNDR-E-MI-27247 |
| MNDR | hsa-mir-206 | Chronic lymphocytic leukemia | MNDR-E-MI-27248 |
| MNDR | hsa-miR-206 | Hirschsprung disease | MNDR-E-MI-27249 |
| MNDR | hsa-mir-206 | Gastric cancer | MNDR-E-MI-27250 |
| MNDR | hsa-miR-206 | Gastric lymphoma | MNDR-E-MI-27251 |
| MNDR | hsa-miR-206 | Pre-eclampsia | MNDR-E-MI-27252 |
| MNDR | hsa-miR-206 | Alzheimer disease | MNDR-E-MI-27253 |
| MNDR | hsa-mir-206 | Alzheimer disease | MNDR-E-MI-27254 |
| MNDR | hsa-mir-206 | Sickle cell diseases | MNDR-E-MI-27255 |
| MNDR | hsa-miR-206 | Urinary bladder cancer | MNDR-E-MI-27256 |
| MNDR | hsa-miR-206 | Esophageal carcinoma | MNDR-E-MI-27257 |
| MNDR | hsa-mir-206 | Distal muscular dystrophy | MNDR-E-MI-27258 |
| MNDR | hsa-mir-206 | Myotonic dystrophy | MNDR-E-MI-27259 |
| MNDR | hsa-miR-206 | Myotonic dystrophy | MNDR-E-MI-27260 |
| MNDR | hsa-miR-206 | Duchenne muscular dystrophy | MNDR-E-MI-27261 |
| MNDR | hsa-mir-206 | Duchenne muscular dystrophy | MNDR-E-MI-27262 |
| MNDR | hsa-mir-206 | Leiomyoma | MNDR-E-MI-27263 |
| MNDR | hsa-miR-206 | Cardiovascular disease | MNDR-E-MI-27264 |
| MNDR | hsa-miR-206 | Dilated cardiomyopathy | MNDR-E-MI-27265 |
| MNDR | hsa-mir-206 | Lung cancer | MNDR-E-MI-27266 |
| MNDR | hsa-miR-206 | Lung cancer | MNDR-E-MI-27267 |
| MNDR | hsa-miR-206 | Facial paralysis | MNDR-E-MI-27268 |
| MNDR | hsa-miR-206 | Down syndrome | MNDR-E-MI-27269 |
| MNDR | hsa-miR-206 | Parkinson disease | MNDR-E-MI-27270 |
| MNDR | hsa-miR-206 | Cognitive dysfunction | MNDR-E-MI-27271 |
| MNDR | hsa-miR-206 | Basal-like breast cancer | MNDR-E-MI-27272 |
| MNDR | hsa-mir-206 | Breast cancer | MNDR-E-MI-27273 |
| MNDR | hsa-mir-206 | Cancer | MNDR-E-MI-27274 |
| MNDR | hsa-miR-206 | Thyroid cancer | MNDR-E-MI-27275 |
| MNDR | hsa-miR-206 | Pituitary neoplasms | MNDR-E-MI-27276 |
| MNDR | hsa-mir-206 | Pancreatic cancer | MNDR-E-MI-27277 |
| MNDR | hsa-miR-206 | Pancreatic cancer | MNDR-E-MI-27278 |
| MNDR | hsa-mir-206 | Malignant melanoma | MNDR-E-MI-27279 |
| MNDR | hsa-miR-206 | Melanoma | MNDR-E-MI-27280 |
| MNDR | hsa-miR-206 | Nephroblastoma | MNDR-E-MI-27281 |
| MNDR | hsa-miR-206 | Colon cancer | MNDR-E-MI-27282 |
| MNDR | hsa-miR-206 | Ischemic attack transient | MNDR-E-MI-27283 |
| MNDR | hsa-miR-206 | Multiple sclerosis relapsing-remitting | MNDR-E-MI-27284 |
| MNDR | hsa-mir-206 | Ovarian cancer | MNDR-E-MI-27285 |
| MNDR | hsa-miR-206 | Prostate adenocarcinoma | MNDR-E-MI-27286 |
| MNDR | hsa-mir-206 | Laryngeal neoplasms | MNDR-E-MI-27287 |
| MNDR | hsa-miR-206 | Mesothelioma | MNDR-E-MI-27288 |
| MNDR | hsa-mir-206 | Carcinoma endometrioid endometrial | MNDR-E-MI-27289 |
| MNDR | hsa-mir-206 | Laryngeal squamous cell carcinoma | MNDR-E-MI-27290 |
| MNDR | hsa-miR-206 | Pulmonary tuberculosis | MNDR-E-MI-27291 |
| MNDR | hsa-mir-206 | Glioblastoma | MNDR-E-MI-27292 |
| MNDR | hsa-miR-206 | Glioblastoma | MNDR-E-MI-27293 |
| MNDR | hsa-miR-206 | Astrocytoma | MNDR-E-MI-27294 |
| MNDR | hsa-miR-206 | Glioma | MNDR-E-MI-27295 |
| MNDR | hsa-mir-206 | Chronic obstructive pulmonary disease | MNDR-E-MI-27296 |
| MNDR | hsa-mir-206 | Rhabdomyosarcoma | MNDR-E-MI-27297 |
| MNDR | hsa-miR-206 | Rhabdomyosarcoma | MNDR-E-MI-27298 |
| MNDR | hsa-mir-206 | Amyotrophic lateral sclerosis | MNDR-E-MI-27299 |
| MNDR | hsa-miR-206 | Amyotrophic lateral sclerosis | MNDR-E-MI-27300 |
| MNDR | hsa-miR-206 | Osteosarcoma | MNDR-E-MI-27301 |
| MNDR | hsa-mir-206 | Osteosarcoma | MNDR-E-MI-27302 |
| MNDR | hsa-miR-206 | Coronary artery disease | MNDR-E-MI-27303 |
| MNDR | hsa-mir-206 | Carcinoma breast | MNDR-E-MI-27304 |
| MNDR | hsa-miR-206 | Pituitary adenoma | MNDR-E-MI-27305 |
| MNDR | hsa-mir-206 | Early-stage lung carcinoma | MNDR-E-MI-27306 |
| MNDR | hsa-miR-206 | Lung squamous cell carcinoma | MNDR-E-MI-27307 |
| MNDR | hsa-mir-206 | Carcinoma lung non-small-cell | MNDR-E-MI-27308 |
| MNDR | hsa-miR-206 | Lung adenocarcinoma | MNDR-E-MI-27309 |
| MNDR | hsa-mir-206 | Lung adenocarcinoma | MNDR-E-MI-27310 |
| MNDR | hsa-mir-206 | Pancreatic adenocarcinoma | MNDR-E-MI-27311 |
| MNDR | hsa-miR-206 | Pancreatic adenocarcinoma | MNDR-E-MI-27312 |
| MNDR | hsa-mir-206 | Muscle diseases | MNDR-E-MI-27313 |
| MNDR | hsa-miR-206 | Cervical cancer | MNDR-E-MI-27314 |
| MNDR | hsa-mir-206 | Cervical cancer | MNDR-E-MI-27315 |
| MNDR | hsa-mir-206 | Carcinoma renal cell | MNDR-E-MI-27316 |
| MNDR | hsa-miR-206 | Kidney chromophobe | MNDR-E-MI-27317 |
| MNDR | hsa-miR-206 | Kidney renal papillary cell carcinoma | MNDR-E-MI-27318 |
| MNDR | hsa-mir-206 | Clear cell renal cell cancer | MNDR-E-MI-27319 |
| MNDR | hsa-miR-206 | Clear cell renal cell carcinoma | MNDR-E-MI-27320 |
| MNDR | hsa-miR-206 | Cholangiocarcinoma | MNDR-E-MI-27321 |
| MNDR | hsa-miR-206 | Esophageal cancer | MNDR-E-MI-27322 |
| MNDR | hsa-mir-206 | Prolactinoma | MNDR-E-MI-27323 |
| MNDR | hsa-mir-206 | Schizophrenia | MNDR-E-MI-27324 |
| MNDR | hsa-miR-206 | Synovial sarcoma | MNDR-E-MI-27325 |
| MNDR | hsa-mir-206 | Head and neck squamous cell carcinoma | MNDR-E-MI-27326 |
| MNDR | hsa-miR-206 | Head and neck squamous cell carcinoma | MNDR-E-MI-27327 |
| MNDR | hsa-mir-206 | Myocardial infarction | MNDR-E-MI-27328 |
| MNDR | hsa-mir-206 | Epithelioid sarcoma | MNDR-E-MI-27329 |
| MNDR | hsa-mir-206 | Pulmonary arterial hypertension | MNDR-E-MI-27330 |
| MNDR | hsa-miR-206 | Hepatocellular carcinoma | MNDR-E-MI-27331 |
| MNDR | hsa-mir-206 | Hepatocellular carcinoma | MNDR-E-MI-27332 |
| MNDR | hsa-miR-206 | B-cell lymphoma | MNDR-E-MI-27333 |
| MNDR | hsa-miR-206 | T-cell leukemia | MNDR-E-MI-27334 |
| MNDR | hsa-miR-206 | Malignant pleural mesothelioma | MNDR-E-MI-27335 |
| MNDR | hsa-miR-206 | Neuroblastoma | MNDR-E-MI-27336 |
| MNDR | hsa-miR-206 | Burkitt lymphoma | MNDR-E-MI-27337 |
| MNDR | hsa-mir-206 | Thrombocytopenic purpurea autoimmune | MNDR-E-MI-27338 |
| MNDR | hsa-miR-206 | Colorectal cancer | MNDR-E-MI-27339 |
| MNDR | hsa-mir-206 | Colorectal cancer | MNDR-E-MI-27340 |
| MNDR | hsa-miR-206 | Nasopharynx carcinoma | MNDR-E-MI-27341 |
| MNDR | hsa-mir-206 | Muscular dystrophy | MNDR-E-MI-27342 |
| MNDR | hsa-mir-206 | Bronchopulmonary dysplasia | MNDR-E-MI-27343 |
| MNDR | hsa-mir-206 | Uterine cervical neoplasms | MNDR-E-MI-27344 |
| MNDR | hsa-mir-206 | Hypertrophy | MNDR-E-MI-27345 |
| MNDR | hsa-mir-206 | Inflammation | MNDR-E-MI-27346 |
| MNDR | hsa-mir-206 | Musculoskeletal abnormalities | MNDR-E-MI-27347 |
| MNDR | hsa-miR-206 | Nasopharyngeal cancer | MNDR-E-MI-27348 |
| MNDR | hsa-miR-206 | Prostatic neoplasms | MNDR-E-MI-27349 |
| MNDR | hsa-mir-206 | Synapses | MNDR-E-MI-27350 |
| MNDR | hsa-mir-206 | Systemic lupus erythematosus susceptibility | MNDR-E-MI-27351 |
| MNDR | hsa-mir-206 | Vascular hypertrophy | MNDR-E-MI-27352 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACTL6A | Homo sapiens | RR00037418 |
TOP